# Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma

> **NCT00941460** · PHASE2 · COMPLETED · sponsor: **Prof. Dr. Wolfgang Wick** · enrollment: 105 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DRUG:** Temozolomide in both arms
- **DRUG:** Temozolomide in both arms

## Key facts

- **NCT ID:** NCT00941460
- **Lead sponsor:** Prof. Dr. Wolfgang Wick
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2014-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00941460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00941460, "Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00941460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*